Dexterdelta Pharma Private Limited

Manufactures, processes, and distributes pharmaceuticals, drugs, and chemicals globally.

2022 | Nashik, Maharashtra (India) | Under Dissolution
Last Updated: July 18, 2024

Dexterdelta Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 3 Year, 22 Days

About Dexterdelta Pharma

Dexterdelta Pharma Private Limited (DPPL) is Under Process Of Striking Off company established on 19 Jan 2022 with its office registered at Nashik, Maharashtra, India and has been running since 3 Year, 22 Days with a paid up capital of 0.10 M. According to MCA records, 4 Directors are linked to this company as of 18 Jul 2024.

Company Details

  • Location

    Nashik, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230MH2022PTC375124

  • Company No.

    375124

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    19 Jan 2022

  • Date of AGM

    -

  • Date of Balance Sheet

    -

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Dexterdelta Pharma?

Board Members (4)

Name Designation Appointment Date Status
Sandip Patil Country flag representing In Director 19-Jan-2022 Current
Shubh Chande Country flag representing In Director 19-Jan-2022 Current
Deepak Chande Country flag representing In Director 19-Jan-2022 Current
Pravin Yeole Country flag representing In Director 19-Jan-2022 Current

Financial Performance of Dexterdelta Pharma.

Enhance accessibility to Dexterdelta Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Dexterdelta Pharma?

Unlock access to Dexterdelta Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Dexterdelta Pharma?

Dexterdelta Pharma has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dexterdelta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dexterdelta Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Dexterdelta Pharma

Recent activity within the organization

  • Director Appointment

    Shubh Deepak Chande was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 3 years 22 days .

    19 Jan 2022

  • Director Appointment

    Sandip Jagannath Patil was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 3 years 22 days .

    19 Jan 2022

  • Director Appointment

    Deepak Kalyanji Chande was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 3 years 22 days .

    19 Jan 2022

  • Director Appointment

    Pravin Suresh Yeole was appointed as a Director was appointed as a Director on 19 Jan 2022 & has been associated with this company since 3 years 22 days .

    19 Jan 2022

  • Company Incorporation

    Dexterdelta Pharma Private Limited was registered on 19 Jan 2022 with Roc Mumbai & aged 3 years 22 days as per MCA records.

    19 Jan 2022

Frequently asked questions

  • Dexterdelta Pharma Private Limited was incorporated on 19 Jan 2022.

  • The authorized share capital of Dexterdelta Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 4 directors are associated with Dexterdelta Pharma Private Limited.

    • Shubh Deepak Chande
    • Sandip Jagannath Patil
    • Deepak Kalyanji Chande
    • Pravin Suresh Yeole
  • As per Ministry of Corporate Affairs (Mca), the registered address of Dexterdelta Pharma Private Limited is Plot No. 4 Sr No. 613/3/5, Near Kalika Mandir Behind Surbhi Hotel, Nashik, Maharashtra, India, 422001.

  • The corporate identification number (CIN) of Dexterdelta Pharma Private Limited is U24230MH2022PTC375124 and the company number is 375124 as per Ministry of Corporate Affairs (MCA).